首页> 外文期刊>ESC Heart Failure >Vascular phenotypes of acute decompensated vs. new-onset heart failure: treatment implications
【24h】

Vascular phenotypes of acute decompensated vs. new-onset heart failure: treatment implications

机译:急性代偿失调与新发性心力衰竭的血管表型:治疗意义

获取原文
           

摘要

Abstract Aims Acute heart failure (HF) is a frequent and life-threatening syndrome with heterogeneous clinical, haemodynamic, and neurohormonal features. This article describes the vascular phenotypes associated with acute decompensated chronic HF (ADCHF), and new-onset acute HF (NOAHF). Data Synthesis Worsening of chronic HF occurs with full activation of adaptive mechanisms that maintain blood pressure (BP) and systemic perfusion. Rapid onset of HF in the setting of previous normal functioning heart not only does not allow full activation of adaptive mechanisms but also generates inappropriate responses from systemic endothelium leading to low BP/hypotension. Consequently, the treatment of ADCHF is based on diuretics and vasodilators, while in NOAHF, vasoconstrictors may be required to maintain BP to allow the correction of the acute cardiac disease. Conclusions Patients with ADCHF and NOAHF present different vascular phenotypes with treatment implications.
机译:摘要目的急性心力衰竭(HF)是一种常见且危及生命的综合征,具有多种临床,血液动力学和神经激素特征。本文介绍与急性失代偿性慢性HF(ADCHF)和新发急性HF(NOAHF)相关的血管表型。数据综合随着维持血压(BP)和全身性灌注的适应性机制的全面激活,慢性HF恶化。在先前的正常功能心脏中,HF的快速发作不仅不能完全激活适应性机制,而且还会因系统性内皮产生不适当的反应,从而导致低血压/​​低血压。因此,ADCHF的治疗基于利尿剂和血管扩张剂,而在NOAHF中,可能需要血管收缩剂维持BP以纠正急性心脏病。结论ADCHF和NOAHF患者表现出不同的血管表型,具有治疗意义。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号